Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia

被引：54
|
作者：
Keating, Amy K. [1 ,2 ]
Gossai, Nathan [3 ]
Phillips, Christine L. [4 ,5 ]
Maloney, Kelly [1 ,2 ]
Campbell, Kristen [1 ,2 ]
Doan, Andrew [6 ]
Bhojwani, Deepa [7 ]
Burke, Michael J. [7 ]
Verneris, Michael R. [1 ,2 ]
机构：
[1] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA
[2] Childrens Hosp Colorado, Aurora, CO USA
[3] Childrens Minnesota, Minneapolis, MN USA
[4] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[5] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[6] Childrens Hosp Los Angeles, Keck Sch Med USC, Los Angeles, CA 90027 USA
[7] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
来源：
BLOOD ADVANCES | 2019年 / 3卷 / 13期
关键词：
THERAPY;
D O I：
10.1182/bloodadvances.2018025726
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1926 / 1929
页数：4
相关论文
共 50 条
  • [1] Blinatumomab and Venetoclax for Minimal Residual Disease Relapse in Acute Lymphoblastic Leukemia
    Campos-Cabrera, Gregorio
    Vega-Tapia, Noe-Benjamin
    Campos-Cabrera, Virgina
    Campos-Cabrera, Salvador
    Campos-Villagomez, Jose-Luis
    Mendez-Garcia, Esther
    BLOOD, 2019, 134
  • [2] Acute Lymphoblastic Leukemia Blinatumomab improved Prognosis for Children with minimal Residual Disease
    Schmale, Ine
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (7-8) : 450 - 451
  • [3] BLINATUMOMAB REDUCES MINIMAL RESIDUAL DISEASE PRIOR TO ALLOGENEIC STEM CELL TRANSPLANT FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Keating, Amy K.
    Gossai, Nathan
    Phillips, Christine L.
    Maloney, Kelly
    Campbell, Kristen
    Doan, Andrew
    Bhojwani, Deepa
    Burke, Michael J.
    Verneris, Michael R.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [4] Application of minimal residual disease monitoring in pediatric patients with acute lymphoblastic leukemia
    Qin, X.
    Zhang, M-Y
    Liu, W-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (20) : 6885 - 6895
  • [5] Detection of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia
    Gaipa, Giuseppe
    Basso, Giuseppe
    Biondi, Andrea
    Campana, Dario
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (06) : 359 - 369
  • [6] Minimal Residual Disease Detected Prior to Transplantation Is Associated with Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
    Foster, Jennifer H.
    Woolfrey, Anne
    Wood, Brent
    Thomson, Blythe
    BLOOD, 2008, 112 (11) : 1115 - 1115
  • [7] IMMUNE FUNCTION AND MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Thompson, Joel
    Auletta, Jeffery
    Muszynski, Jennifer
    Hall, Mark
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S33 - S33
  • [8] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2018, 131 (14) : 1522 - 1531
  • [9] Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Campana, Dario
    SEMINARS IN HEMATOLOGY, 2009, 46 (01) : 100 - 106
  • [10] Minimal Residual Disease in Acute Lymphoblastic Leukemia
    Patil, Pratik P.
    Jafa, Esha
    Aggarwal, Mayank
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (01) : 71 - 76
12345